New Guidelines Recommend Shorter, All-Oral Regimens for Drug-Susceptible and Drug-Resistant Tuberculosis Medha Baranwal16 Jan 2025 8:00 PM ISTUSA: An international panel of experts has released guidelines advocating for shorter, all-oral drug regimens for both drug-susceptible (DS) and...
Bedaquiline-based regimen improves outcomes in drug resistant tuberculosis, suggests study Jacinthlyn Sylvia22 Oct 2024 8:00 PM ISTA new study published in the Journal of Clinical Tuberculosis and Other Mycobacterial Diseases showed that two bedaquiline-containing regiments...
New Algorithm to Enhance Diagnosis and Treatment of Drug-Resistant Bone, Joint, and Spine Tuberculosis: Study Medha Baranwal14 Sept 2024 9:00 AM ISTIndia: In a major development, the researchers have identified an algorithm for identifying presumptive drug resistance (PDR) in spinal and bone...
Three drug regimen with Linezolid 600 mg tied to better outcomes in Drug-resistant TB: NEJM Dr.Niharika Harsha B1 Sept 2022 8:00 PM ISTThe three-drug regimen with Linezolid at a dosage of 600 mg for 26 weeks has shown promising outcomes in drug-resistant Tuberculosis in 84-93% of...
BLK-Max Hospital collaborates with Govt to provide DR-TB medications free of cost Adity Saha8 July 2022 2:30 PM ISTThe new drug-resistant Tuberculosis (DR-TB) will be available only at government-designated centres and BLK-Max Hospital
WHO recommends shorter treatment regimens for drug-resistant tuberculosis Medha Baranwal5 May 2022 10:45 AM ISTUSA: The World Health Organization (WHO) has updated its guideline for the treatment of drug-resistant tuberculosis.In its updated released guideline...
